arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

NATURES SUNSHINE PRODUCTS INC

NATR
$16.28 ▼ -4.04 (-19.86%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

NATURES SUNSHINE PRODUCTS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $293.1M
Dividend Yield
Revenue Growth 5.7%
Op. Margin 5.2%
ROIC None
FCF / Share $1.60
Trailing P/E 15.1x
Price / Book
FCF Yield 9.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$480.14M
↑ +5.7%
Net Income Profit after all expenses
$19.52M
↑ +153.7%
Operating Margin Operating profit as % of sales
5.2%
↑ +16.5% 43th
FCF / Share Free cash flow per share
$1.60
↑ +108.1%
Long-Term Debt Long-term obligations
$1.17M
↓ -51.4%

Health Breakdown

Profitability
46
Financial Health
97
Cash Quality
79

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share
-100.0% YoY

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters